Hyderabad Telangana, India

Suresh Babu Namani

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biophore India Pharmaceuticals Pvt. Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suresh Babu Namani. Retrieved from https://idiyas.com/inventor/suresh-babu-namani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suresh Babu Namani: Innovator in Pharmaceutical Chemistry

Introduction

Suresh Babu Namani is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of gadolinium complexes.

Latest Patents

Suresh Babu Namani holds a patent for a novel process for the preparation of gadolinium complex of (4S)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedioic acid disodium, commonly known as Gadoxetate disodium. This invention discloses a unique method for synthesizing this complex and its novel intermediates.

Career Highlights

He is currently associated with Biophore India Pharmaceuticals Pvt. Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy and safety of pharmaceutical compounds.

Collaborations

Suresh collaborates with talented professionals in his field, including Manik Reddy Pullagurla and Bhaskar Reddy Pitta, contributing to a dynamic research environment.

Conclusion

Suresh Babu Namani's contributions to pharmaceutical chemistry, particularly through his patented processes, highlight his role as an innovator in the industry. His work continues to impact the development of advanced medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…